Global JE vaccine Market Professional Survey Report 2016
- QYR570258
- 177 Pages
- May 2016
- Pharmaceuticals
Mainly covers the following product types
Inactivated JE vaccine
Live attenuated JE vaccine
The segment applications including
Hospital use
Home use
Segment regions including (the separated region report can also be offered)
USA
China
UK
France
Switzerland
Japan
The players list (Partly, Players you are interested in can also be added)
MSD
Wyeth
Chengdu Institute
NOVARTIS
Pfizer
Merck
Abbott Laboratories
ZhiFei
HUALAN
Liaoning Yisheng
Lanzhou Institute
Merck Sharp & Dohme
Sanofi Pasteur
Aventis Pasteur S.A.
Takeda Pharmaceutical
Wuhan Institute
Zhejiang Tianyuan
Liaoning Chengda
TIANTAN
With no less than 15 top producers.
Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of JE vaccine
1.1 Definition and Specifications of JE vaccine
1.1.1 Definition of JE vaccine
1.1.2 Specifications of JE vaccine
1.1.2.1 0.5ml/bottle
1.2 Classification of JE vaccine
1.2.1 Inactivated JE vaccine
1.2.2 Live attenuated JE vaccine
1.3 Applications of JE vaccine
1.3.1 Hospital use
1.3.2 Home use
1.4 Industry Chain Structure of JE vaccine
1.5 Industry Overview and Major Regions Status of JE vaccine
1.5.1 Industry Overview of JE vaccine
1.5.2 Global Major Regions Status of JE vaccine
1.6 Industry Policy Analysis of JE vaccine
1.7 Industry News Analysis of JE vaccine
2 Manufacturing Cost Structure Analysis of JE vaccine
2.1 Raw Material Suppliers and Price Analysis of JE vaccine
2.2 Equipment Suppliers and Price Analysis of JE vaccine
2.3 Labor Cost Analysis of JE vaccine
2.4 Other Costs Analysis of JE vaccine
2.5 Manufacturing Cost Structure Analysis of JE vaccine
2.6 Manufacturing Process Analysis of JE vaccine
3 Technical Data and Manufacturing Plants Analysis of JE vaccine
3.1 Capacity and Commercial Production Date of Global JE vaccine Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global JE vaccine Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global JE vaccine Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global JE vaccine Major Manufacturers in 2015
4 Global JE vaccine Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global JE vaccine Capacity and Growth Rate Analysis
4.2.2 2015 JE vaccine Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global JE vaccine Sales and Growth Rate Analysis
4.3.2 2015 JE vaccine Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global JE vaccine Sales Price
4.4.2 2015 JE vaccine Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global JE vaccine Gross Margin
4.5.2 2015 JE vaccine Gross Margin Analysis (Company Segment)
5 JE vaccine Regional Market Analysis
5.1 USA JE vaccine Market Analysis
5.1.1 USA JE vaccine Market Overview
5.1.2 USA 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.1.3 USA 2011-2016E JE vaccine Sales Price Analysis
5.1.4 USA 2015 JE vaccine Market Share Analysis
5.2 China JE vaccine Market Analysis
5.2.1 China JE vaccine Market Overview
5.2.2 China 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.2.3 China 2011-2016E JE vaccine Sales Price Analysis
5.2.4 China 2015 JE vaccine Market Share Analysis
5.3 UK JE vaccine Market Analysis
5.3.1 UK JE vaccine Market Overview
5.3.2 UK 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.3.3 UK 2011-2016E JE vaccine Sales Price Analysis
5.3.4 UK 2015 JE vaccine Market Share Analysis
5.4 France JE vaccine Market Analysis
5.4.1 France JE vaccine Market Overview
5.4.2 France 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.4.3 France 2011-2016E JE vaccine Sales Price Analysis
5.4.4 France 2015 JE vaccine Market Share Analysis
5.5 Switzerland JE vaccine Market Analysis
5.5.1 Switzerland JE vaccine Market Overview
5.5.2 Switzerland 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Switzerland 2011-2016E JE vaccine Sales Price Analysis
5.5.4 Switzerland 2015 JE vaccine Market Share Analysis
5.6 Japan JE vaccine Market Analysis
5.6.1 Japan JE vaccine Market Overview
5.6.2 Japan 2011-2016E JE vaccine Local Supply, Import, Export, Local Consumption Analysis
5.6.3 Japan 2011-2016E JE vaccine Sales Price Analysis
5.6.4 Japan 2015 JE vaccine Market Share Analysis
6 Global 2011-2016E JE vaccine Segment Market Analysis (by Type)
6.1 Global 2011-2016E JE vaccine Sales by Type
6.2 Different Types JE vaccine Product Interview Price Analysis
6.3 Different Types JE vaccine Product Driving Factors Analysis
6.3.1 Inactivated JE vaccine JE vaccine Growth Driving Factor Analysis
6.3.2 Live attenuated JE vaccine JE vaccine Growth Driving Factor Analysis
7 Global 2011-2016E JE vaccine Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Hospital use JE vaccine Growth Driving Factor Analysis
7.3.2 Home use JE vaccine Growth Driving Factor Analysis
8 Major Manufacturers Analysis of JE vaccine
8.1 MSD
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 MSD 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 MSD 2015 JE vaccine Business Region Distribution Analysis
8.2 Wyeth
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Wyeth 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Wyeth 2015 JE vaccine Business Region Distribution Analysis
8.3 Chengdu Institute
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Chengdu Institute 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Chengdu Institute 2015 JE vaccine Business Region Distribution Analysis
8.4 NOVARTIS
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 NOVARTIS 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 NOVARTIS 2015 JE vaccine Business Region Distribution Analysis
8.5 Pfizer
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Pfizer 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Pfizer 2015 JE vaccine Business Region Distribution Analysis
8.6 Merck
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Merck 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Merck 2015 JE vaccine Business Region Distribution Analysis
8.7 Abbott Laboratories
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Abbott Laboratories 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Abbott Laboratories 2015 JE vaccine Business Region Distribution Analysis
8.8 ZhiFei
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 ZhiFei 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 ZhiFei 2015 JE vaccine Business Region Distribution Analysis
8.9 HUALAN
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 HUALAN 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 HUALAN 2015 JE vaccine Business Region Distribution Analysis
8.10 Liaoning Yisheng
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Liaoning Yisheng 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Liaoning Yisheng 2015 JE vaccine Business Region Distribution Analysis
8.11 Lanzhou Institute
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Lanzhou Institute 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Lanzhou Institute 2015 JE vaccine Business Region Distribution Analysis
8.12 Merck Sharp & Dohme
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Merck Sharp & Dohme 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Merck Sharp & Dohme 2015 JE vaccine Business Region Distribution Analysis
8.13 Sanofi Pasteur
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Sanofi Pasteur 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Sanofi Pasteur 2015 JE vaccine Business Region Distribution Analysis
8.14 Aventis Pasteur S.A.
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Aventis Pasteur S.A. 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Aventis Pasteur S.A. 2015 JE vaccine Business Region Distribution Analysis
8.15 Takeda Pharmaceutical
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Takeda Pharmaceutical 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Takeda Pharmaceutical 2015 JE vaccine Business Region Distribution Analysis
8.16 Wuhan Institute
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Wuhan Institute 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Wuhan Institute 2015 JE vaccine Business Region Distribution Analysis
8.17 Zhejiang Tianyuan
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Zhejiang Tianyuan 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Zhejiang Tianyuan 2015 JE vaccine Business Region Distribution Analysis
8.18 Liaoning Chengda
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Liaoning Chengda 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Liaoning Chengda 2015 JE vaccine Business Region Distribution Analysis
8.19 TIANTAN
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 TIANTAN 2015 JE vaccine Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 TIANTAN 2015 JE vaccine Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 USA 2016-2021 JE vaccine Consumption Forecast
9.2.2 China 2016-2021 JE vaccine Consumption Forecast
9.2.3 UK 2016-2021 JE vaccine Consumption Forecast
9.2.4 France 2016-2021 JE vaccine Consumption Forecast
9.2.5 Switzerland 2016-2021 JE vaccine Consumption Forecast
9.2.6 Japan 2016-2021 JE vaccine Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 JE vaccine Marketing Model Analysis
10.1 JE vaccine Regional Marketing Model Analysis
10.2 JE vaccine International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of JE vaccine by Regions
10.4 JE vaccine Supply Chain Analysis
11 Consumers Analysis of JE vaccine
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of JE vaccine
12.1 New Project SWOT Analysis of JE vaccine
12.2 New Project Investment Feasibility Analysis of JE vaccine
13 Conclusion of the Global JE vaccine Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
